公开(公告)号：EP1897881A2

公开(公告)日：2008-03-12

申请号：EP07122274.9

申请日：2003-06-19

申请人： Biovitrum AB (publ)

发明人： Johansson, Gary ,  Jenmalm Jensen, Annika ,  Beierlein, Katarina

IPC分类号： C07D471/04 ,  C07D495/04 ,  A61P3/00 ,  A61K31/4365

CPC分类号： C07D471/04 ,  C07D495/04

摘要： The present invention relates to compounds of the general formula (I),

wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.

公开(公告)号：EP1897881A8

公开(公告)日：2010-08-11

申请号：EP07122274.9

申请日：2003-06-19

申请人： Biovitrum AB (publ)

发明人： Johansson, Gary ,  Jenmalm Jensen, Annika ,  Beierlein, Katarina

IPC分类号： C07D471/04 ,  C07D495/04 ,  A61P3/00 ,  A61K31/4365

CPC分类号： C07D471/04 ,  C07D495/04

摘要： The present invention relates to compounds of the general formula (I),

wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.

公开(公告)号：EP1897881A3

公开(公告)日：2009-03-18

申请号：EP07122274.9

申请日：2003-06-19

申请人： Biovitrum AB (publ)

发明人： Johansson, Gary ,  Jenmalm Jensen, Annika ,  Beierlein, Katarina

IPC分类号： C07D471/04 ,  C07D495/04 ,  A61P3/00 ,  A61K31/4365

CPC分类号： C07D471/04 ,  C07D495/04

摘要： The present invention relates to compounds of the general formula (I),

wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.

公开(公告)号：EP1897876A3

公开(公告)日：2009-03-18

申请号：EP07122269.9

申请日：2003-06-19

申请人： Biovitrum AB (publ)

发明人： Johansson, Gary ,  Jenmalm Jensen, Annika ,  Beierlein, Katarina

IPC分类号： C07D401/04 ,  C07D215/46 ,  C07D217/22 ,  A61P3/00 ,  A61K31/4706

CPC分类号： C07D471/04 ,  C07D495/04

摘要： The present invention relates to compounds of the general formula (I),

wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.

公开(公告)号：EP1897876A2

公开(公告)日：2008-03-12

申请号：EP07122269.9

申请日：2003-06-19

申请人： Biovitrum AB (publ)

发明人： Johansson, Gary ,  Jenmalm Jensen, Annika ,  Beierlein, Katarina

IPC分类号： C07D401/04 ,  C07D215/46 ,  C07D217/22 ,  A61P3/00 ,  A61K31/4706

CPC分类号： C07D471/04 ,  C07D495/04

摘要： The present invention relates to compounds of the general formula (I),

wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.

摘要翻译： 本发明涉及通式（I）的化合物，其中P是砜或磺酰胺; A，B，W，X，Y和R3如说明书中所定义; 涉及包含这些化合物的药物组合物，以及涉及这些化合物用于预防和治疗与肥胖症，II型糖尿病和/或CNS疾病有关的医学病症的用途，以实现体重和体重增加的降低。